Aspen Pharmacare Holdings (APNHF) Income Statement
Aspen Pharmacare Holdings Income Statement
Last quarter (Q4 2026), Aspen Pharmacare Holdings's total revenue was $18.30B, a decrease of 22.36% from the same quarter last year. In Q4, Aspen Pharmacare Holdings's net income was $1.21B. See Aspen Pharmacare Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 34.98B | $ 43.36B | $ 44.71B | $ 40.71B | $ 38.61B | |
| $ 14.10B | $ 19.13B | $ 19.45B | $ 18.41B | $ 18.31B | |
| $ 8.68B | $ 17.69B | $ 12.46B | $ 9.46B | $ 9.47B | |
| Depreciation and Amortization | $ 1.92B | $ 2.09B | $ 1.97B | $ 1.79B | $ 1.71B |
| $ 7.34B | $ 3.62B | $ 9.91B | $ 9.67B | $ 10.61B | |
| $ 5.42B | $ 1.44B | $ 7.00B | $ 7.82B | $ 8.67B | |
| $ -5.84B | $ -1.56B | $ -1.28B | $ -1.27B | $ -537.00M | |
| $ -419.32M | $ -123.00M | $ 5.71B | $ 6.55B | $ 8.13B | |
| $ 2.66B | $ -1.08B | $ 4.40B | $ 5.23B | $ 6.49B | |
| Per Share Metrics | |||||
| Basic EPS | $ 5.96 | $ -2.44 | $ 9.91 | $ 11.77 | $ 14.32 |
| Diluted EPS | $ 5.96 | $ -2.44 | $ 9.91 | $ 11.77 | $ 14.32 |
| Weighted Average Shares Outstanding | 444.10M | 444.00M | 444.20M | 444.20M | 453.00M |
| Weighted Average Shares Outstanding (Diluted) | 444.10M | 444.00M | 444.20M | 444.20M | 453.00M |
Currency in ZAR